Paysign (PAYS)
Runs prepaid payment programs for plasma centers, drugmakers, and healthcare clients.
$12.91
After hours0.00 (0.00%)
At close$12.91(+2.22%)
In millions of USD, except per-share figures
| In millions | Q3 FY23Sep 2023 | Q4 FY23Dec 2023 | Q1 FY24Mar 2024 | Q2 FY24Jun 2024 | Q3 FY24Sep 2024 | Q4 FY24Dec 2024 | Q1 FY25Mar 2025 | Q2 FY25Jun 2025 | Q3 FY25Sep 2025 | Q4 FY25Dec 2025 | Q1 FY26Mar 2026 | Q2 FY26Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 12 | 14 | 13 | 14 | 15 | 16 | 19 | 19 | 22 | 23 | 28 | 28 |
| Cost of revenue | 6 | 7 | 6 | 7 | 7 | 6 | 7 | 7 | 9 | 12 | 12 | 10 |
| Gross profit | 6 | 7 | 7 | 8 | 8 | 9 | 12 | 12 | 12 | 11 | 16 | 18 |
| 6 | 7 | 7 | 7 | 8 | 9 | 9 | 10 | 11 | 9 | 9 | 11 | |
| 5 | 6 | 0 | 0 | 0 | 7 | 0 | 0 | 0 | 9 | 9 | 9 | |
| Selling & marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & administrative | 0 | 5 | 0 | 0 | 0 | 7 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other expenses | 1 | 1 | 7 | 7 | 8 | 2 | 9 | 10 | 11 | 0 | 0 | 2 |
| Operating income | 1 | 1 | 0 | 0 | 1 | 0 | 2 | 1 | 2 | 2 | 7 | 7 |
| 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |
| Interest income | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Other non-operating income | −1 | 0 | −1 | −1 | −1 | −1 | −1 | −1 | −1 | −1 | −1 | −1 |
| Income before tax | 1 | 1 | 0 | 1 | 1 | 1 | 3 | 2 | 2 | 2 | 7 | 8 |
| Income tax expense | 0 | −4 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 1 | 2 | 1 |
| Net income from continuing operations | 1 | 6 | 0 | 1 | 1 | 1 | 3 | 1 | 2 | 1 | 5 | 7 |
| Net income | 1 | 6 | 0 | 1 | 1 | 1 | 3 | 1 | 2 | 1 | 5 | 7 |
| EPS, basic | $0.02 | $0.11 | $0.01 | $0.01 | $0.03 | $0.03 | $0.05 | $0.03 | $0.04 | $0.02 | $0.10 | $0.12 |
| EPS, diluted | $0.02 | $0.10 | $0.01 | $0.01 | $0.03 | $0.02 | $0.05 | $0.02 | $0.04 | $0.02 | $0.09 | $0.11 |
| Weighted average shares, basic | 53 | 53 | 53 | 53 | 53 | 53 | 54 | 54 | 55 | 55 | 55 | 56 |
| Weighted average shares, diluted | 53 | 54 | 55 | 56 | 56 | 56 | 55 | 58 | 62 | 62 | 61 | 62 |
| EBITDA | 2 | 2 | 2 | 2 | 3 | 3 | 5 | 4 | 4 | 5 | 10 | 8 |
| Depreciation & amortization | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 3 | 0 |
| EBIT | 1 | 0 | 0 | 1 | 1 | 1 | 3 | 2 | 2 | 2 | 7 | 8 |